Loading Events

« All Events

  • This event has passed.

Client Webinar Session – OurCrowd – Pursuit of Tech and Innovation – COVID-19

May 12, 2020 @ 16:00 - 17:00 AEST

Time: 4pm Sydney time

Date: 12th May 2020

Cathryn Carver, Executive General Manager, Client Coverage, Corporate and Institutional Banking NAB, together with Dan Bennett, Managing Partner – OurCrowd, are delighted to be hosting a special webinar presentation and Q&A live from Israel.

‘Insights on the Coronavirus and lessons from other lethal viruses’ with Dr Ron Diskin from the Department of Structural Biology, Weizmann Institute of Science, and Professor Itamar Shalit, Migal Vaccine.

The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, just south of Tel Aviv. The institute was established in 1934 and today is comprised of 250 experimental and theoretical research groups. Weizmann scientists are credited with inventing breakthrough cancer drugs, amniocentesis, blockbuster drugs for multiple sclerosis, nano materials and compounds for industrial and medical uses, and advanced computer technologies.

Migal is a leading internationally-recognised multi-disciplinary non-profit research institute located in Israel’s Northern Galilee. Migal was established in 1979, and today is addressing the world’s most pressing challenges by research in agriculture, food, health and the environment. Over the past four years Migal has developed an oral vaccine for a Coronavirus strain in chickens which has now been adapted for COVID-19 in humans. Migal has established MigVax for the purpose of commercialising their proprietary chimeric protein vaccine against COVID-19 which will begin human testing within 90 days.

This event is invite only.


May 12, 2020
16:00 - 17:00 AEST
Event Category: